Some people are discovering that being thinner can sometimes mean looking older. Local cosmetic surgeons weigh-in with ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

In recent times, medications like Ozempic (semaglutide) have gained popularity not only for managing type 2 diabetes but also ...

A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...

Eight weeks. That’s how long it takes, on average, for the pounds to begin creeping back after someone stops taking the world ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

GLP-1 drugs like Ozempic and Mounjaro helped men with low testosterone raise their levels without hormone replacement in a ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...